In contrast to increased phosphorylation of Stat-1, we did not detect phosphorylated Stat-6 (Tyr641) (not shown), suggesting that Stat-1-specific signaling is preferential over Stat-6-specific activation in MS lesions. This evidence concerns the gene STAT1 and myeloid sarcoma.